Cancer Protein Description

This report provides a detailed description of a selected cancer protein with information collected from various sources, including UniProt, the Wellcome Trust Sanger Institute’s Catalogue of Somatic Mutations in Cancer (COSMIC), and the Atlas of Genetics and Cytogenetics in Oncology and Haematology.


Protein Name: HUWE1
Gene Name: HUWE1
Protein Full Name: E3 ubiquitin-protein ligase HUWE1
Alias: ARF-binding protein 1; ARF-BP1; E3 ubiquitin protein ligase URE-B1; HECT, UBA and WWE domain containing 1; HECT, UBA and WWE domain-containing protein 1; Homologous to E6AP carboxyl terminus homologous protein 9; HSPC272; Ib772; KIAA0312; KIAA1578; Large structure of UREB1; Mcl-1 ubiquitin ligase E3; Mule; Upstream regulatory element-binding protein 1; UREB1
Mass (Da): 481891
Number AA: 4374
UniProt ID: Q7Z6Z7
Locus ID: 10075
COSMIC ID: HUWE1
Gene location on chromosome: Xp11.22
Cancer protein type: OP
Effect of cancer mutation on protein: GAIN
Effect of active protein on cancer: PROMOTES
Number of cancer specimens: 20055
Percent of cancer specimens with mutations: 2.74
General distribution of mutations: Multi-site
Location of most mutations: Broad distribution of mutation sites with several point mutations and 1 deletion, but no complex or insertion mutants.
Normal role description: HUWE1 is part of the HECT E3 ubiquitin ligase family. It is involved in ubiquitination and degradation of many targets such as MCL1, DNA polymerase beta, p53, H1, H2A, H2B, H3, and H4. These proteins are involved regulation of apoptosis, DNA repair, cell cycle arrest and chromatin modeling. Overexpression leads to dysregulation of DNA repair, progression of cell cycle and promote oncogenesis.


Provide the gene name, protein name, UniProt ID or Locus ID as a search term. Click on Retrieve Info button to obtain information on the selected cancer protein.